TokenPost·
MBX Biosciences Posts $1.29 GAAP Loss Per Share in Q3
The company expects its $481.6 million in cash and investments to support operations into 2029.
More news
- TokenPostRobinhood Says It Does Not Object to OKXICE Tokenized Shares
- TokenPostCisco and IBM Plan Separate Claude Mythos Security Integrations
- TokenPostWallet 0x7a8 Sells Aster (ASTER) in Repeated Batches Over Six Days
- TokenPostAltcoin Volume Was Normal by Nov. 10 After Hitting Four Times Bitcoin (BTC) Trading Volume
- TokenPostGalaxy Digital Swings to $323 Million Profit in Third Quarter
- TokenPostBinance Bitcoin Perpetual Book Shows $15.38 Million in Bids at $75,200